Lexaria Bioscience's total assets for Q1 2025 were $9.79M, an increase of 10.44% from the previous quarter. LEXX total liabilities were $399.72K for the fiscal quarter, a -66.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.